SCHEMBL6918516

SCHEMBL6918516

CC(C)(C)[Si](C)(C)OOO[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9794154 0.85
SCHEMBL14560468 0.76
SCHEMBL15810776 0.73
SCHEMBL31432779 0.73 TSHR (0.41)
SCHEMBL8278 0.69
SCHEMBL5609364 0.67
Hydrochloric Acid SCHEMBL16047936 0.67
SCHEMBL28477 0.67
SCHEMBL15093993 0.66 ALDH1A1 (0.30)
SCHEMBL31222804 0.66 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220000883-A1 PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO EMORY UNIVERSITY 2022-01-06 US disclosed
CN-109563323-B Polypropylene-based resin composition LG化学株式会社 2021-12-03 CN disclosed
US-11077120-B2 Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto EMORY UNIVERSITY (US) 2021-08-03 US disclosed
CN-108329443-B high-Florichaugs parameter block polymer and random polymer for oriented self-assembly, and preparation method and self-assembly method thereof 北京科华微电子材料有限公司 2020-10-09 CN disclosed
EP-3137074-B1 PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO UNIV EMORY (US) 2020-08-05 EP disclosed
US-20200085837-A1 Prostaglandin Receptor EP2 Antagonists, Derivatives, Compositions, and Uses Related Thereto UNIV EMORY (US) 2020-03-19 US disclosed
US-10568889-B2 Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto EMORY UNIVERSITY (US) 2020-02-25 US disclosed
US-20180318315-A1 Prostaglandin Receptor EP2 Antagonists, Derivatives, Compositions, and Uses Related Thereto NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-11-08 US disclosed
US-10052332-B2 Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto EMORY UNIVERSITY (US) 2018-08-21 US disclosed
EP-3137074-A1 PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO Emory University (US) 2017-03-08 EP disclosed
WO-1991003474-A1 HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES PFIZER INC. (US) 1991-03-21 WO disclosed
US-4983627-A Treating atherosclerosis, thrombosis and vasospasms; anticholesterol,-secretory,-ulcer and hypotensive agents SYNTEX (U.S.A.) INC. (US) 1991-01-08 US disclosed
EP-0378318-A1 Process for synthesis of FK-506 and tricarbonyl intermediates MERCK & CO. INC. (US) 1990-07-18 EP disclosed
EP-0332332-A1 Hypoglycemic thiazolidinedione derivatives PFIZER INC. (US) 1989-09-13 EP disclosed
US-4525586-A Composition and process THE UPJOHN COMPANY (US) 1985-06-25 US disclosed
US-4420632-A PROSTAGLANDINS; ANTICOAGULANTS THE UPJOHN COMPANY (US) 1983-12-13 US disclosed
US-4418206-A 9-Deoxy-9-methylene derivatives of (dl)-16-phenoxy and 16-phenoxy substituted prostatriene compounds SYNTEX (U.S.A.) INC. (US) 1983-11-29 US disclosed
US-4349689-A Methano carbacyclin analogs THE UPJOHN COMPANY (US) 1982-09-14 US disclosed
US-4306075-A Composition and process THE UPJOHN COMPANY (US) 1981-12-15 US disclosed
US-4306076-A Inter-phenylene CBA compounds THE UPJOHN COMPANY (US) 1981-12-15 US disclosed